Protara Therapeutics Inc. share price logo

Protara Therapeutics Inc.

NASDAQ: TARA

$3.98

+0.04

(+1.02%)

as on

Protara Therapeutics Inc. Stock Performance

as on August 15, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.83
    $4.00
    downward going graph

    3.77%

    Downside

    0.50%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.97
    $7.82
    downward going graph

    25.38%

    Downside

    96.48%

    Upside

    downward going graph

Protara Therapeutics Inc. share price movements today

Previous Close
$3.94
Open
$3.90
Volume
670.9K
Day's Low - High
$3.83 - $4.00
52 Week Low - High
$2.97 - $7.82

Protara Therapeutics Inc. Historical Returns

1 Month Return
-3.67 %
3 Month Return
-25.66 %
1 Year Return
+ 23.51 %
3 Year Return
+ 64.85 %
5 Year Return
-43.95 %

Protara Therapeutics Inc. Stock Fundamentals & Key Indicators

Check Protara Therapeutics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$229.9M

EPS (TTM)

-1.3875

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-76.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-45.80%

Protara Therapeutics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Protara Therapeutics Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Protara Therapeutics Inc. image
Protara Therapeutics Inc.
BUY$229.9M-43.95%NA0.00%NA
Revolution Medicines Inc. image
Revolution Medicines Inc.
BUY$44.0B690.3%NA0.00%NA
Vertex Pharmaceuticals Inc. image
Vertex Pharmaceuticals Inc.
BUY$133.3B165.71%30.8735.00%NA
Regeneron Pharmaceuticals Inc. image
Regeneron Pharmaceuticals Inc.
BUY$82.2B29%19.7227.87%0.45999999999999996%

Stock Returns calculator for Protara Therapeutics Inc. Stock including INR - Dollar returns

The Protara Therapeutics Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Protara Therapeutics Inc. investment value today

Current value as on today

₹1,35,754

Returns

₹35,754

(+35.75%)

Returns from Protara Therapeutics Inc. Stock

₹24,765 (+24.76%)

Dollar Impact

₹10,990 (+10.99%)

Analyst Recommendation on Protara Therapeutics Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Protara Therapeutics Inc.. Average target price of $26.57

Protara Therapeutics Inc. Share Price Target

Get share price movements and forecasts by analysts on Protara Therapeutics Inc..

What analysts predicted

85.02%UPSIDE

Target Price

$26.57

Current Price

$3.98

Analyzed by

11 Analysts

Target

$26.57

Protara Therapeutics Inc. target price $26.57, a slight upside of 85.02% compared to current price of $3.98. According to 11 analysts rating.

Indian Investors' Interest in Protara Therapeutics Inc. Stock

Search interest for Protara Therapeutics Inc. Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-50% versus previous 30 day period

Protara Therapeutics Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
0
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-11
-10
-12
-14
-14
-16
-14
-19
-19
EBITDA
-11
-9
-11
-12
-11
-14
-13
-17
-17
Interest Expense
-
-
-
-
1
1
1
-
1
Depreciation
0
0
0
0
0
0
0
0
0
Income Before Tax
-11
-9
-11
-12
-11
-14
-13
-17
-17
Income Tax Expense
0
-
-
-
-
-
-
-
-
Net Income
-11
-9
-11
-12
-11
-14
-13
-17
-17
Net Profit Margin
0.00%
0.00%
0.00%
-3846.08%
0.00%
0.00%
0.00%
0.00%
0.00%

Protara Therapeutics Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
-1
0
0
0
0
Operating Income
-15
-34
-47
-67
-43
-49
-64
EBITDA
-7
-33
-45
-64
-40
-44
-57
Interest Expense
-
0
1
1
-
4
-
Depreciation
0
0
0
0
0
0
0
Income Before Tax
-14
-33
-47
-65
-40
-44
-57
Income Tax Expense
0
0
0
-1
0
-
-
Net Income
-14
-33
-47
-65
-40
-44
-57
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Protara Therapeutics Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-9
-11
-12
-11
-14
-13
-17
-17
-21
Operating Cash Flow
-7
-8
-9
-14
-12
-12
-16
-21
-14
Investing Cash Flow
2
-29
22
-58
-47
-6
-26
-14
17
Financing Cash Flow
42
-
97
1
0
0
80
1
-1
Change in Cash
37
-37
111
-71
-59
-18
37
-34
2

Protara Therapeutics Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-29
-20
-14
-33
-47
-65
-40
-44
-57
Operating Cash Flow
-22
-23
-15
-23
-34
-26
-37
-35
-56
Investing Cash Flow
-16
18
2
2
-98
14
53
19
-139
Financing Cash Flow
23
2
0
189
0
0
0
139
82
Change in Cash
-15
-1
-13
168
-132
-11
15
123
-113

Global Institutional Holdings in Protara Therapeutics Inc.

Funds
Holdings
UBS Group AG
2.55%
Opaleye Management Inc
2.22%
Woodline Partners LP
2.21%
Geode Capital Management, LLC
2.14%
Millennium Management LLC
5.14%
See all

Insights on Protara Therapeutics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 573.3% return, outperforming this stock by 508.4%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 460.8% return, outperforming this stock by 437.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TARA stock has moved down by -4.4%

About Protara Therapeutics Inc.

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy for patients receiving parenteral nutrition and fluids. The company is headquartered in New York, New York.
OrganisationProtara Therapeutics Inc.
Headquarters345 Park Avenue South, New York, NY, United States, 10010
IndustryBiotechnology
CEOMr. Jesse Shefferman
E-voting on sharesClick here to vote

Key Management of Protara Therapeutics Inc.

Name

Title

Dr. Jacqueline Zummo M.B.A., M.P.H., Ph.D.

Co-Founder, Chief R&D Officer

Mr. Patrick Fabbio M.B.A.

Chief Financial Officer

Mr. William Conkling

Chief Commercial Officer

Carla Beckham M.D., Ph.D.

Lead Medical Director, Head of Clinical Development of TARA-002 in NMIBC & Board-Certified Urologist

Dr. Neal D. Shore F.A.C.S., M.D.

Medical Director of START Carolinas/ Carolina Urologic Research Center

Mr. Jesse Shefferman

Co-founder, CEO, President & Director

Ms. Hannah Fry

VP, Principal Accounting Officer & Controller

Ms. Justine O'Malley

Senior Vice President of Investor Relations & Corporate Affairs

Ms. Mary J. Grendell J.D.

General Counsel & Corporate Secretary

Dr. Shane Williams Ph.D.

Chief People Officer

FAQs

What is Protara Therapeutics Inc. share price today?

Protara Therapeutics Inc. share price today is $3.98 as on at the close of the market. Protara Therapeutics Inc. share today touched a day high of $4.00 and a low of $3.83.

What is the 52 week high and 52 week low for Protara Therapeutics Inc. share?

Protara Therapeutics Inc. share touched a 52 week high of $7.82 on and a 52 week low of $2.97 on . Protara Therapeutics Inc. stock price today i.e. is closed at $3.98,which is 49.10% down from its 52 week high and 34.01% up from its 52 week low.

What is Protara Therapeutics Inc.'s market capitalisation today?

Protara Therapeutics Inc. market capitalisation is $0.00T as on .

How to invest in Protara Therapeutics Inc. Stock (TARA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Protara Therapeutics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protara Therapeutics Inc. Shares that will get you 0.3769 shares as per Protara Therapeutics Inc. share price of $3.98 per share as on August 15, 2026 at 1:29 am IST.

What is the minimum amount required to buy Protara Therapeutics Inc. Stock (TARA) from India?

Indian investors can start investing in Protara Therapeutics Inc. (TARA) shares with as little as ₹95.415 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹954.15 in Protara Therapeutics Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Protara Therapeutics Inc. share’s latest price of $3.98 as on August 15, 2026 at 1:29 am IST, you will get 2.5126 shares of Protara Therapeutics Inc.. Learn more about fractional shares .

What are the returns that Protara Therapeutics Inc. has given to Indian investors in the last 5 years?

Protara Therapeutics Inc. stock has given -43.95% share price returns and 28.68% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?